Yi Ping Li

Yi Ping Li

Chief Executive Officer presso JW (CAYMAN) THERAPEUTICS CO. LTD

Patrimonio netto: 5 M $ in data 31/03/2024

59 anni
Health Technology
Finance
Consumer Services

Profilo

Yi Ping Li is the Chairman & Chief Executive Officer of JW (Cayman) Therapeutics Co. Ltd.
which he founded in 2017.
He is also the founder of JW Biotechnology (Shanghai) Co. Ltd., JW Therapeutics (Shanghai) Co., Ltd.
and holds the title of Director at GenScript Corp.
Dr. Li's former positions include Medical Director at Merck Serono SA from 1996 to 2006, Director at China Kanghui Holdings from 2009 to 2010, Partner at Kleiner Perkins Caufield & Byers LLC, Principal at KPCB (China) Advisory Co. Ltd., and General Manager at Amgen Biotechnology Consulting Shanghai Co., Ltd.
from 2012 to 2015.
Dr. Li received a graduate degree from The University of Montana in 1991 and a doctorate degree from Shanghai Jiao Tong University in 1987.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
07/06/2023 22 042 212 ( 5.34% ) 5 M $ 31/03/2024

Posizioni attive di Yi Ping Li

SocietàPosizioneInizio
JW (CAYMAN) THERAPEUTICS CO. LTD Chief Executive Officer 14/11/2017
Director/Board Member 27/07/2010
JW Biotechnology (Shanghai) Co. Ltd. Founder -
Chief Executive Officer -
Tutte le posizioni attive di Yi Ping Li

Precedenti posizioni note di Yi Ping Li

SocietàPosizioneFine
Amgen Biotechnology Consulting Shanghai Co., Ltd. Chief Executive Officer 01/07/2015
Director/Board Member 08/11/2010
Corporate Officer/Principal 30/08/2006
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Yi Ping Li

Formazione di Yi Ping Li

The University of Montana Graduate Degree
Shanghai Jiao Tong University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Yi Ping Li

Relazioni

99

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
JW (CAYMAN) THERAPEUTICS CO. LTD

Health Technology

Aziende private8

Finance

Health Technology

Finance

Health Technology

Health Technology

JW Biotechnology (Shanghai) Co. Ltd.

Health Technology

Amgen Biotechnology Consulting Shanghai Co., Ltd.

Vedi le connessioni aziendali